Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Helius Medical Technologies Inc HSDT

Helius Medical Technologies, Inc. is a neurotech company in the medical device field. It is focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms enhancing the lives of people dealing with neurologic diseases. It develops, licenses, or acquires non-implantable technologies targeted at reducing symptoms of neurological disease or trauma. Its product Portable Neuromodulation Stimulator (PoNS) is a non-implantable medical device, inclusive of a controller and mouthpiece, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. PoNS Therapy is integral to the overall PoNS solution and is the physical therapy applied by patients during use of the PoNS neuromodulation stimulator. PoNS is used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only.


NDAQ:HSDT - Post by User

Post by prokofievon Mar 04, 2019 11:50am
182 Views
Post# 29438636

Heuro Canada's First Client Begins Treatment

Heuro Canada's First Client Begins Treatment

Heuro Canada's First Client Begins Innovative Neurological Treatment at Canada's First Heuro PoNS™ Clinic

Canada NewsWire

MONTREAL, March 4, 2019

Leader in traumatic brain injury management completes first client intake to receive groundbreaking treatment program for gait and balance symptoms from previous mild-to-moderate traumatic brain injuries (mTBI)

MONTREAL, March 4, 2019 /CNW/ - Heuro Canada Inc., a top provider of innovative neurological health solutions, announces the first client has completed intake to begin the revolutionary Heuro Program featuring the non-invasive Portable Neuromodulation Stimulator (PoNS™) Treatment at Neurotherapy Montreal, Heuro's first clinic to offer the Health-Canada approved treatment in Canada.

Neurotherapy Montreal is the first licensed clinic in Canada to offer powerful therapeutic treatment designed to help individuals experiencing chronic balance deficits. Combining physical therapy with Helius Medical Technologies' PoNS™ neurotechnology, the Heuro Program allows clients to manage and treat neurological symptoms associated with mild-to-moderate traumatic brain injuries over a 14-week period.

Rudi van den Broek, Managing Director of Heuro Canada, says "the first client to start the Heuro PoNS™ treatment is a significant milestone for Heuro, which aims to improve the quality of life for Canadians experiencing gait and balance symptoms from previous mild-to-moderate traumatic brain injuries."

Nicole Strachan, clinical lead for Heuro Canada, says the treatment plan will focus on the personal rehabilitation of each client.

"Although it is a set program, each therapeutic plan is highly individualized to the needs of the client," she says, "making it possible for Canadians to reach their personal goals of recovery and aim to improve their overall wellbeing."

The PoNS™ Device is the first patented non-invasive means for delivering neurostimulation through the tongue and is designed to amplify the brain's powerful ability to heal itself. The neurotechnology offers a transformative treatment experience with a high success rate.

Neurotherapy Montreal applies existing rehabilitation and recovery training procedures in conjunction with the latest neuromodulation and neuroscience technologies. The clinic helps individuals restore their livelihood and overcome neurological symptoms from previous mild-to-moderate traumatic brain injuries.

Heuro Canada is continuing to deploy the Heuro Program featuring the PoNS™ Treatment in licensed clinics across Canada. With plans to open subsequent clinics in major urban areas, the company aims to improve the quality of life for Canadians experiencing persistent deficiencies, such as gait and balance, from past mild-to-moderate brain injuries. 


Bullboard Posts